Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Refine by:

Programme

Country

Albania (3)
Algeria (1)
Argentina (5)
Australia (8)
Austria (85)
Bangladesh (2)
Belarus (2)
Belgium (135)
Benin (3)
Bolivia (2)
Bosnia and Herzegovina (1)
Botswana (1)
Brazil (4)
Bulgaria (10)
Burkina Faso (6)
Cambodia (1)
Cameroon (3)
Canada (7)
Chile (4)
China (5)
Colombia (2)
Croatia (8)
Cyprus (5)
Czech Republic (29)
Côte d’Ivoire (1)
Democratic Republic of the Congo (4)
Denmark (69)
Ecuador (2)
Egypt (5)
Estonia (15)
Ethiopia (1)
Finland (61)
Former Yugoslav Republic of Macedonia (1)
France (290)
Gabon (1)
Georgia (1)
Germany (383)
Ghana (13)
Greece (35)
Guinea-Bissau (1)
Hong Kong (2)
Hungary (34)
Iceland (5)
India (19)
Indonesia (1)
Ireland (54)
Israel (84)
Italy (215)
Japan (2)
Kenya (7)
Latvia (7)
Lebanon (1)
Lithuania (13)
Luxembourg (5)
Malawi (5)
Malaysia (2)
Mali (6)
Mexico (1)
Montenegro (1)
Morocco (3)
Mozambique (2)
Nepal (3)
Netherlands (195)
New Zealand (1)
Nigeria (4)
Norway (34)
Paraguay (1)
Peru (3)
Philippines (1)
Poland (31)
Portugal (46)
Romania (16)
Russia (8)
Senegal (4)
Serbia (1)
Singapore (1)
Slovakia (10)
Slovenia (14)
South Africa (11)
South Korea (3)
Spain (182)
Sudan (3)
Sweden (154)
Switzerland (146)
Taiwan (1)
Tanzania (8)
Thailand (2)
The Gambia (1)
Togo (2)
Tunisia (6)
Turkey (13)
Uganda (9)
United Arab Emirates (1)
United Kingdom (376)
United States (35)
Uruguay (3)
Venezuela (3)
Vietnam (4)
Zambia (1)
Zimbabwe (2)

Content Type

Project (449)
News (1655)
Event (984)
Result in Brief (1419)
Report Summary (471)
Top Story (36)
Programme (133)

Language

Deutsch (669)
English (1786)
Español (668)
Français (673)
Italiano (677)
Polski (674)

Advanced search

Results 1 - 10 of 5147
Results/page:
12 3 4 5 6 7 8 9 10 > >| 
Nanopartikel und das Immunsystem
Nanotechnologie ist eine Neuerung, von der niemand wirklich weiß, wohin sie uns führt. Die Prognosen reichen von der Fähigkeit, Dinge wie Diamanten und Lebensmittel zu reproduzieren bis hin zu einer Welt die durch selbst-replizierende Nanoroboter verschlungen wird. Bis vor k...
Record Number: 35512
Last updated on: 2013-02-12
Available languages: DE, EN, ES, FR, IT, PL
Exploiting plants for the production of future generation recombinant pharmaceuticals
ID: 269110
Start date: 2011-08-01, End date: 2018-01-31
Biopharmaceutical proteins are typically produced in cultivated mammalian cells, a costly process with limited scalability. Thus products such as monoclonal antibodies are very expensive and often beyond the reach of the world’s poor. The problem is compounded by the fact tha...
Programme: FP7-IDEAS-ERC
Record Number: 99830
Last updated on: 2017-05-26
Mid-Term Report Summary - FUTURE-PHARMA (Exploiting plants for the production of future generation recombinant pharmaceuticals)
The major objective of the Future-Pharma project is to develop innovative ways to use plants for the economic, safe and sustainable production of regulator-approved combinations of active pharmaceutical ingredients based on recombinant proteins. We focus on the production of...
Programme: FP7-IDEAS-ERC
Record Number: 180279
Last updated on: 2016-04-18
Innovative anti-influenza drugs excluding viral escape
ID: 259842
Start date: 2011-06-01, End date: 2016-11-30
ANTIFLU is to develop innovative drugs against influenza virus infections based on a novel concept that precludes the development of viral resistance and ensures efficacy against upcoming pandemic influenza strains. Viral replication is known to depend on multiple host factor...
Programme: FP7-HEALTH
Record Number: 99759
Last updated on: 2017-05-26
Periodic Report Summary - ANTIFLU (Innovative anti-influenza drugs excluding viral escape)
Project context and objectives: The aim of the ANTIFLU project is to develop new and alternative drugs against influenza by exploiting the crucial function of host cell determinants as targets of small molecules and interference ribonucleic acid (RNAi) inhibitors, so-called...
Programme: FP7-HEALTH
Record Number: 56788
Last updated on: 2013-06-12
Periodic Report Summary 2 - ANTIFLU (Innovative anti-influenza drugs excluding viral escape)
Project Context and Objectives:The aim of the ANTIFLU project is to develop new and alternative drugs against influenza by exploiting the crucial function of host cell determinants as targets of small molecules and RNAi inhibitors, so-called indirect antiviral targets, in...
Programme: FP7-HEALTH
Record Number: 156282
Last updated on: 2015-02-10
Dianas indirectas contra la gripe
Las gripes estacionales y el riesgo a la aparición de cepas virales pandémicas explican la urgencia de la necesidad de disponer de nuevas medidas de tratamiento. La estrategia propuesta en el estudio europeo ANTIFLU es dirigir el tratamiento hacia el hospedador y no hacia el propio virus.
Programme: FP7-HEALTH
Record Number: 91917
Last updated on: 2013-10-17
Available languages: DE, EN, ES, FR, IT, PL
Indirect anti-influenza targets
Seasonal influenza infections and the threat of pandemic viral strains scream for innovative measures. The European ANTIFLU study proposes to target the host instead of the virus itself.
Programme: FP7-HEALTH
Record Number: 91917
Last updated on: 2013-10-17
Available languages: DE, EN, ES, FR, IT, PL
Les cibles antigrippales indirectes
Les infections grippales saisonnières et la menace de souches virales pandémiques appellent des mesures urgentes. L'étude européenne ANTIFLU propose de cibler l'organisme hôte plutôt que le virus lui-même.
Programme: FP7-HEALTH
Record Number: 91917
Last updated on: 2013-10-17
Available languages: DE, EN, ES, FR, IT, PL
Pośrednie cele w zwalczaniu grypy
Grypa sezonowa i zagrożenie pandemicznymi szczepami wymagają innowacyjnych działań zaradczych. Europejskie badanie ANTIFLU sugeruje, że należy szukać celów molekularnych u gospodarza, zamiast uderzać bezpośrednio w wirusy.
Programme: FP7-HEALTH
Record Number: 91917
Last updated on: 2013-10-17
Available languages: DE, EN, ES, FR, IT, PL
12 3 4 5 6 7 8 9 10 > >| 
List retrieved on: 2017-05-28
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top